These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11570072)

  • 21. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes among patients with end-stage liver disease who are coinfected with HIV and hepatitis C virus.
    Neff GW; Shire NJ; Rudich SM
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S50-5. PubMed ID: 16265614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coinfection with hepatitis C virus and HIV].
    Ruys TA; Reesink HW; Lange JM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2056-60. PubMed ID: 14606352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of death shift over time.
    TreatmentUpdate; 2001; 12(12):15-6. PubMed ID: 11570083
    [No Abstract]   [Full Text] [Related]  

  • 25. The difficulty in timing for liver transplantation in cirrhotic patients coinfected with HIV: in search for a prognosis score.
    Samuel D; Duclos-Vallee JC
    Liver Transpl; 2006 May; 12(5):699-701. PubMed ID: 16628704
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study).
    Rosenthal E; Pialoux G; Bernard N; Pradier C; Rey D; Bentata M; Michelet C; Pol S; Perronne C; Cacoub P;
    J Viral Hepat; 2007 Mar; 14(3):183-8. PubMed ID: 17305884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 28. Summaries for patients. Comparison of survival among HIV-infected and noninfected people in Denmark, 1995-2005.
    Ann Intern Med; 2007 Jan; 146(2):I39. PubMed ID: 17227931
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV/hepatitis co-infection.
    Rockstroh J
    J HIV Ther; 2007 Mar; 12(1):1. PubMed ID: 17589388
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
    Martín-Carbonero L; Sánchez-Somolinos M; García-Samaniego J; Núñez MJ; Valencia ME; González-Lahoz J; Soriano V
    J Viral Hepat; 2006 Dec; 13(12):851-7. PubMed ID: 17109686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coinfection with HIV and hepatitis C virus and immune restoration during HAART.
    Manfredi R
    Clin Infect Dis; 2006 Jan; 42(2):298-9. PubMed ID: 16355345
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver transplantation in HIV/hepatitis co-infection.
    Miro JM; Aguero F; Laguno M; Tuset M; Cervera C; Moreno A; Garcia-Valdecasas JC; Rimola A;
    J HIV Ther; 2007 Mar; 12(1):24-35. PubMed ID: 17589393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus and metabolic disturbances.
    Nuñez M
    IAPAC Mon; 2005 Jul; 11(7):216-7. PubMed ID: 16676426
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid.
    Núñez-Fernández C; Martín-Carbonero L; Valencia ME; Aguilera J; García-Samaniego J; Gonzalez-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):383-5. PubMed ID: 19320566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 36. Liver ultrastructural morphology and mitochondrial DNA levels in HIV/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy.
    Matsukura M; Chu FF; Au M; Lu H; Chen J; Rietkerk S; Barrios R; Farley JD; Montaner JS; Montessori VC; Walker DC; Côté HC
    AIDS; 2008 Jun; 22(10):1226-9. PubMed ID: 18525271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus.
    Cooper CL; Parbhakar MA; Angel JB
    Clin Infect Dis; 2002 May; 34(9):1259-63. PubMed ID: 11941553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis Cs effect on HIV disease remains elusive despite three new studies.
    Crabb C
    AIDS; 2006 Feb; 20(3):N1-2. PubMed ID: 16439863
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hepatic transplantation in HIV-HCV co-infected patients].
    Gadano A; Aziz H; Macias S; Villamil F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S70-3; discussion S74-82. PubMed ID: 16862868
    [No Abstract]   [Full Text] [Related]  

  • 40. Editorial comment: liver disease in the HIV-infected patient--the courage to treat.
    Dieterich DT
    AIDS Read; 2003 Oct; 13(10):500-1. PubMed ID: 14596228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.